Low Price/Earning Purchases

Demo data is delayed six months. Subscribe today and get current information.  Learn More »

Select a new report:

Largest purchases at companies with price/earnings ratio of 12 or less. Companies with low P/E ratios traditionally have limited downside, and when coupled with bullish insider buying may indicate good investment opportunities.

Filter by: 





Trades reported from 03-Jan-20 to 04-Jan-20
Number of records: 1
Last ReportedCompanyIndustry GroupIndustry# InsidersHistorical Avg Return (6 Mo)Last TradeAvg. PriceTotal SharesTotal
03-Jan-20 7:45 PMOcular Therapeutix, Inc (OCUL) DrugsBiotechnology1(2%)
(5 decisions)
02-Jan-20$3.9015,000$58,507.50